Meta-analysis of 9 studies (3 RCTs, 6 cohorts; n=148,267) of pregnant individuals: RSVpreF vaccination vs none or placebo was associated with slightly higher hypertensive disorders of pregnancy risk (RR 1.08, 95% CI 1.02–1.13), driven by observational data; RCTs non-significant.
Meta-analysisn = 148,267
Alami et al. Maternal vaccination with RSVpreF and risk of hypertensive disorders of pregnancy: a systematic review and meta-analysis